Reply: Subgroup Differences in Response to 8 Weeks of Ledipasvir/Sofosbuvir for Chronic Hepatitis C.

ABSTRACT:

SUBMITTER: O'Brien TR 

PROVIDER: S-EPMC4567096 | biostudies-literature | 2015 Apr

REPOSITORIES: biostudies-literature